CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 77 filers reported holding CUE BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $827,400 | -38.8% | 359,739 | -2.9% | 0.24% | -35.0% |
| Q2 2023 | $1,351,986 | -18.8% | 370,407 | -20.6% | 0.38% | -26.1% |
| Q1 2023 | $1,664,852 | +17.5% | 466,345 | -6.2% | 0.51% | +19.2% |
| Q4 2022 | $1,416,954 | +38.5% | 497,177 | +8.4% | 0.43% | +9.2% |
| Q3 2022 | $1,023,000 | -7.4% | 458,851 | +3.4% | 0.39% | -18.5% |
| Q2 2022 | $1,105,000 | +402.3% | 443,851 | +886.3% | 0.48% | +452.9% |
| Q1 2022 | $220,000 | – | 45,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,915,219 | $23,959,000 | 5.70% |
| Prosight Management, LP | 906,569 | $11,341,000 | 5.24% |
| P.A.W. CAPITAL CORP | 140,000 | $1,751,000 | 1.54% |
| Voss Capital, LLC | 220,714 | $2,761,000 | 1.39% |
| Robertson Stephens Wealth Management, LLC | 484,000 | $6,054,000 | 1.26% |
| Slate Path Capital LP | 1,483,619 | $18,560,000 | 1.00% |
| Nantahala Capital Management | 2,506,772 | $31,360,000 | 0.97% |
| PRECEPT MANAGEMENT LLC | 150,000 | $1,877,000 | 0.76% |
| SANDERS MORRIS HARRIS LLC | 193,591 | $2,449,000 | 0.56% |
| Rock Creek Group, LP | 100,014 | $1,251,000 | 0.51% |